Management of a Primary Retroperitoneal Yolk Sac Tumor.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
27 Oct 2021
27 Oct 2021
Historique:
entrez:
27
10
2021
pubmed:
28
10
2021
medline:
30
10
2021
Statut:
epublish
Résumé
BACKGROUND Existing literature has detailed occurrences of retroperitoneal yolk sac tumors (YSTs) as the result of metastasis from a primary gonadal site. However, primary retroperitoneal YSTs are extremely rare, thus remaining a challenge to diagnose and treat. We present a complex case of a large primary retroperitoneal YST in a man treated with neoadjuvant chemotherapy followed by surgical resection. CASE REPORT A 31-year-old man presented with a chief symptom of severe lower abdominal pain. Diagnostic imaging revealed a large, rapidly progressing neoplasm in the retroperitoneal region, initially thought to be a sarcoma. However, the pathological results from further biopsies found the mass to be a retroperitoneal YST, which was tethered to a large portion of the small bowel. A testicular ultrasound was used to confirm that the mass was a primary tumor with no origins in the gonads. The tumor progressed to involve several fistulas connected to the small intestine and anterior abdominal wall. The patient was treated with 3 cycles of bleomycin, etoposide, and cisplatin, followed by surgical excision of the residual mass. The patient retained normal gastrointestinal functions, and subsequent imaging revealed no evidence of recurrence 2.5 years following resection. CONCLUSIONS Owing to the rarity of extragonadal primary YSTs, diagnostic and treatment standards have not yet been sufficiently explored. Our case demonstrates that a combination of chemotherapy and surgical resection should be considered for select patients with primary YST in the retroperitoneal region.
Identifiants
pubmed: 34705815
pii: 933258
doi: 10.12659/AJCR.933258
pmc: PMC8557854
doi:
Substances chimiques
Etoposide
6PLQ3CP4P3
Cisplatin
Q20Q21Q62J
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e933258Références
Pediatr Neurosurg. 1996;24(5):242-51
pubmed: 8933567
Contemp Oncol (Pozn). 2013;17(6):530-2
pubmed: 24592142
Int J Androl. 2012 Aug;35(4):616-25
pubmed: 22320869
Cancer Med. 2019 Nov;8(16):6832-6840
pubmed: 31568647
J Clin Oncol. 2002 Apr 1;20(7):1864-73
pubmed: 11919246
J Clin Oncol. 2001 Mar 15;19(6):1641-8
pubmed: 11250992
Scand J Urol Nephrol. 2001 Dec;35(6):515-7
pubmed: 11848434
Am J Surg Pathol. 2006 Jul;30(7):858-65
pubmed: 16819328
Cancer Res. 2000 Mar 15;60(6):1475-82
pubmed: 10749107
Adv Anat Pathol. 2007 Mar;14(2):69-92
pubmed: 17471115
Oncol Lett. 2014 Aug;8(2):556-560
pubmed: 25009643
Int J Gynecol Cancer. 2018 May;28(4):713-720
pubmed: 29461339
J Urol. 1996 Jul;156(1):85-8
pubmed: 8648846
Cancer. 1981 Jan 1;47(1):19-21
pubmed: 6161688